News

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...
Investing.com -- Tivic Health Systems, Inc. (NASDAQ:TIVC) stock surged 55% on Thursday after the company announced progress in discussions with key U.S. government agencies regarding the potential use ...
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025 ...
August 14, 2025Traws Pharma, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-8.75. Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Traws Pharma, ...
One of the more notable successes of President Donald Trump’s first term was how the administration was able to develop ...
Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...
On Aug. 5, Robert F. Kennedy Jr. posted video to X announcing HHS was canceling mRNA vaccine research, confusing the Trump ...
San Diego CDMO TriLink BioTechnologies is reducing its headcount while its parent company, Maravai LifeSciences, moves ...
Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, ...
Doctors and scientists who spoke to HuffPost are worried for a multitude of reasons and want you to know that this will ...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...